Cargando…
A Novel Marker for Predicting Fulminant Myocarditis: Systemic Immune–Inflammation Index
In myocarditis, the search for effective and appropriate prognostic biomarkers can help clinicians identify high-risk patients in a timely manner and make better medical decisions in clinical practice. The prognostic value of systemic immune–inflammatory index (SII), an innovate biomarker of inflamm...
Autores principales: | Yaradilmiş, Raziye Merve, Güneylioğlu, Muhammed Mustafa, Öztürk, Betül, Göktuğ, Aytaç, Aydın, Orkun, Güngör, Ali, Bodur, İlknur, Kaya, Özkan, Örün, Utku Arman, Karacan, Can Demir, Tuygun, Nilden |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389492/ https://www.ncbi.nlm.nih.gov/pubmed/35984471 http://dx.doi.org/10.1007/s00246-022-02988-9 |
Ejemplares similares
-
Evaluation of changes in pediatric emergency department utilization during COVID-19 pandemic
por: Tuygun, Nilden, et al.
Publicado: (2021) -
Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019) -
Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020) -
Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020) -
COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)